| Schedule of basic and diluted income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net income (in thousands) |
|
$ |
150,723 |
|
$ |
164,400 |
|
$ |
303,104 |
|
$ |
300,270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - basic |
|
|
31,324,833 |
|
|
31,599,744 |
|
|
31,483,144 |
|
|
31,575,337 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive effect of common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
34,973 |
|
|
25,052 |
|
|
38,083 |
|
|
23,848 |
RSAs with market-based conditions |
|
|
61,856 |
|
|
20,039 |
|
|
61,491 |
|
|
22,450 |
RSAs with performance-based conditions |
|
|
10,885 |
|
|
1,974 |
|
|
17,474 |
|
|
15,503 |
Stock options |
|
|
91,516 |
|
|
84,998 |
|
|
93,332 |
|
|
85,522 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - diluted |
|
|
31,524,063 |
|
|
31,731,807 |
|
|
31,693,524 |
|
|
31,722,660 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per common share |
|
$ |
4.81 |
|
$ |
5.20 |
|
$ |
9.63 |
|
$ |
9.51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per common share |
|
$ |
4.78 |
|
$ |
5.18 |
|
$ |
9.56 |
|
$ |
9.47 |
|
| Summary of shares excluded from the calculation of diluted income per share because their effect would have been anti-dilutive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Anti-dilutive common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
- |
|
|
- |
|
|
- |
|
|
5,582 |
|
RSAs with market-based conditions |
|
|
- |
|
|
- |
|
|
- |
|
|
4,467 |
|
RSAs with performance-based conditions |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Stock options |
|
|
- |
|
|
14,801 |
|
|
- |
|
|
18,541 |
|
Total anti-dilutive common stock equivalents |
|
|
- |
|
|
14,801 |
|
|
- |
|
|
28,590 |
|
|